Label Changes for:

Crestor (Rosuvastatin Calcium) Tablets

August 2013

Changes have been made to the WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

 

August 2013

 

WARNINGS AND PRECAUTIONS

Endocrine Effects
  • Based on clinical trial data with Crestor, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus…
 
Hide
(web1)